Dostarlimab plus chemotherapy followed by dostarlimab plus niraparib maintenance therapy among patients with primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Mirza, Mansoor; Ghamande, Sharad; Hanker, Lars; Black, Destin; Raascou-Jensen, Nicoline; Gilbert, Lucy; Oaknin, Ana; Secord, Angeles Alvarez; Savarese, Antonella; Holloway, Robert; Kristeleit, Rebecca; Buscema, Joseph; Boere, Ingrid; Sharma, Sudarshan; Gennigens, Christine; Ghatage, Prafull; Yablonski, Kaitlin; Stevens, Shadi; Trukhan, Hanna; Powell, Matthew

Publication Date

  • October 9, 2024

webpage

published in

category

start page

  • S6

end page

  • S6

volume

  • 190